Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: A double-blind clinical trial study

Inhalation phage therapy is proposed as a replacement approach for antibiotics in the treatment of pulmonary bacterial infections. This study investigates phage therapy on bacterial pneumonia in patients with moderate to severe COVID-19 via the inhalation route. In this double-blind clinical trial,...

Descripción completa

Detalles Bibliográficos
Autores principales: Samaee, Hamid Reza, Eslami, Gohar, Rahimzadeh, Golnar, Saeedi, Majid, Davoudi Badabi, Alireza, Asare-Addo, Kofi, Nokhodchi, Ali, Roozbeh, Fatemeh, Moosazadeh, Mahmood, Ghasemian, Roya, Alikhani, Ahmad, Rezai, Mohammad Sadegh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116154/
https://www.ncbi.nlm.nih.gov/pubmed/37123173
http://dx.doi.org/10.1016/j.jddst.2023.104486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116154/
https://www.ncbi.nlm.nih.gov/pubmed/37123173
http://dx.doi.org/10.1016/j.jddst.2023.104486

Ejemplares similares